NEW YORK, Nov. 15 (GenomeWeb News) - Transgenomic has sold its oligonucleotide-manufacturing facility and laid off 60 staffers worldwide as the struggling company takes steps to trim expenses and save cash, the company disclosed today.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.
Technology Review points out that a new US presidential science advisor hasn't been selected.
Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.
President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.